ConductScience.org, home

Paper26316700

RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer.

Feng C and 5 others. Drug Des Devel Ther, 2015. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer. Papers, record 26316700. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26316700

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer.
PubMed
Journal
Drug Des Devel Ther
PubMed
Year
2015
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.46
iCite
Revised in PubMed
2019-02-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Feng CChan
2Li XXiaoyan
3Dong CChunyan
4Zhang XXuemei
5Zhang XXie
6Gao YYong

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AclarubicinMajor topic
AdenocarcinomaMajor topic
Antibiotics, AntineoplasticMajor topic
LipidsMajor topic
Lung NeoplasmsMajor topic
OligopeptidesMajor topic
Adenocarcinoma of Lung
Animals
Area Under Curve
Cell Line, Tumor
Chemistry, Pharmaceutical
Delayed-Action Preparations
Drug Stability
Half-Life
Injections, Intravenous
Liposomes
Mice, Inbred BALB C
Mice, Nude
Particle Size
Rats
Solubility
Tumor Burden
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122490676Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin.Blood2012https://conductscience.org/library/papers/22490676PubMed
28970741RGD and other recognition sequences for integrins.Annu Rev Cell Dev Biol1996https://conductscience.org/library/papers/8970741PubMed
322888235Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats.Int J Nanomedicine2012https://conductscience.org/library/papers/22888235PubMed
422967287RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis.Mol Pharm2012https://conductscience.org/library/papers/22967287PubMed
523973508Effects of mycophenolic acid-glucosamine conjugates on the base of kidney targeted drug delivery.Int J Pharm2013https://conductscience.org/library/papers/23973508PubMed
623959851Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.Pharm Res2013https://conductscience.org/library/papers/23959851PubMed
723957267Liposomes in drug delivery: a patent review (2007 - present).Expert Opin Ther Pat2013https://conductscience.org/library/papers/23957267PubMed
823979293Synthesis of VIP-lipopeptide using a new linker to modify liposomes: towards the development of a drug delivery system for active targeting.Chem Pharm Bull (Tokyo)2013https://conductscience.org/library/papers/23979293PubMed
924070211Bone regeneration potential of stem cells derived from periodontal ligament or gingival tissue sources encapsulated in RGD-modified alginate scaffold.Tissue Eng Part A2014https://conductscience.org/library/papers/24070211PubMed
1024611009GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation.Int J Nanomedicine2014https://conductscience.org/library/papers/24611009PubMed
1125371296Formulation, characterization, and in vitro/vivo studies of aclacinomycin A-loaded solid lipid nanoparticles.Drug Deliv2016https://conductscience.org/library/papers/25371296PubMed
1211948551Antitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E, cholesterol, and PEG-lipid.J Pharm Sci2002https://conductscience.org/library/papers/11948551PubMed
1312234975Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo.Cancer Res2002https://conductscience.org/library/papers/12234975PubMed
1412470989Probing the structural and molecular diversity of tumor vasculature.Trends Mol Med2002https://conductscience.org/library/papers/12470989PubMed
1512516034Role of angiogenesis in tumor growth and metastasis.Semin Oncol2002https://conductscience.org/library/papers/12516034PubMed
169377570Aclacinomycin A stabilizes topoisomerase I covalent complexes.Cancer Res1997https://conductscience.org/library/papers/9377570PubMed
179359101On target with tumor blood vessel markers.Nat Biotechnol1997https://conductscience.org/library/papers/9359101PubMed
1817896915Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers.Anticancer Agents Med Chem2007https://conductscience.org/library/papers/17896915PubMed
1917826969Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.Eur J Pharm Biopharm2008https://conductscience.org/library/papers/17826969PubMed
2021475772A novel family of RGD-containing disintegrins (Tablysin-15) from the salivary gland of the horsefly Tabanus yao targets αIIbβ3 or αVβ3 and inhibits platelet aggregation and angiogenesis.Thromb Haemost2011https://conductscience.org/library/papers/21475772PubMed

See all 23 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
40051630Aclacinomycin enhances the killing effect of allogeneic NK cells on acute myeloid leukemia cells by inducing immunogenic cell death.Front Immunol2025https://conductscience.org/library/papers/40051630PubMed
36985733Rethinking Biosynthesis of Aclacinomycin A.Molecules2023https://conductscience.org/library/papers/36985733PubMed
29075099
Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers.
Drug Des Devel Ther2017https://conductscience.org/library/papers/29075099PubMed
28721013A novel local anesthetic system: transcriptional transactivator peptide-decorated nanocarriers for skin delivery of ropivacaine.Drug Des Devel Ther2017https://conductscience.org/library/papers/28721013PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FGB2244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
VTN7448PubTator's text mininghttps://conductscience.org/library/genes/7448NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26316700

GET https://conductscience.org/api/papers/v1/26316700/references?page=2